Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.
about
Anthroposophic therapy for chronic depression: a four-year prospective cohort studyInterventions for helping people recognise early signs of recurrence in depressionThe Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intakeTargeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinicPopulation-based study of first onset and chronicity in major depressive disorderNeurobiology of depression: an integrated view of key findingsMarkov models of major depression for linking psychiatric epidemiology to clinical practice.Melanin-Concentrating Hormone (MCH): Role in REM Sleep and DepressionAssociations of the Ratios of n-3 to n-6 Dietary Fatty Acids With Longitudinal Changes in Depressive Symptoms Among US Women.Depression and functioning in relation to health care use in sickle cell diseaseWhy People Are in a Generally Good Mood.A major depression prognosis calculator based on episode duration.The validity of proxy-based data in suicide research: a study of patients 50 years of age and older who attempted suicide. I. Psychiatric diagnoses.White blood cell inflammatory markers are associated with depressive symptoms in a longitudinal study of urban adults.NATURALISTIC COURSE OF MAJOR DEPRESSIVE DISORDER PREDICTED BY CLINICAL AND STRUCTURAL NEUROIMAGING DATA: A 5-YEAR FOLLOW-UP.Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.Quality and customers: Type 2 change in mental health delivery within health care reform.The sex-specific role of plasma folate in mediating the association of dietary quality with depressive symptoms.A clinical study of the efficacy of a single session of individual exercise for depressive patients, assessed by the change in saliva free cortisol level.Depression and social support among HIV-affected adolescentsNew episodes and new onsets of major depression in borderline and other personality disorders.Efficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trialsIdentification of emotional facial expressions following recovery from depressionEmotion regulation in depression: relation to cognitive inhibition.Effectiveness of psychotherapeutic, pharmacological, and combined treatments for chronic depression: a systematic review (METACHRON)Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.Specificity of cognitive biases in patients with current depression and remitted depression and in patients with asthmaDoes processing of emotional stimuli predict symptomatic improvement and diagnostic recovery from major depression?Theta-burst transcranial magnetic stimulation in depression: when less may be morePathways linking socioeconomic status to obesity through depression and lifestyle factors among young US adults.A 2-year prospective follow-up study of the course of obsessive-compulsive disorder.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology.Refractory depression: treatment strategies, with particular reference to the thyroid axis.Chronic depression: a case series of 203 outpatients treated at a private practiceImprovement in self-reported quality of life with cognitive therapy for recurrent major depressive disorder.Are anxiety and depression addressed in primary care patients with chronic obstructive pulmonary disease? A chart reviewDeep brain stimulation for psychiatric disorders.Bupropion and sertraline combination treatment in refractory depression.Successful application of adaptive emotion regulation skills predicts the subsequent reduction of depressive symptom severity but neither the reduction of anxiety nor the reduction of general distress during the treatment of major depressive disordePosttraumatic stress disorder in African Americans: a two year follow-up study
P2860
Q21260277-C7C0A925-DC9E-4B4D-8EF0-8EAAD951197AQ24247096-10642E9D-F8BE-4009-8E66-F6C995188B69Q24595149-EDA821C6-11E4-4FEB-9E20-F2EA95243100Q24647348-916BDEB1-22B4-4030-86A7-5FE1B7A8A6DAQ24653412-E06497AF-BA6E-486A-A842-D9EF35993E51Q24655216-AD0AE971-582A-462F-9EB7-D7A140A61225Q24810421-37BBCEE8-8EAB-46D1-89B4-B771BB6C39F6Q26770777-FF451B7A-FFA3-410B-858E-B17D8994D6D0Q27304687-365D0209-F853-4D53-932A-81BAD1D82431Q30433520-B083672F-8D87-4148-BB8A-0CB05240FD67Q30459185-55164103-E89C-4D5D-9BBB-754DAFF931F3Q30477763-72CEFCCF-C654-4AF0-8686-CBD5ADF3F179Q30659590-1C48539D-9776-4737-9AC7-A6729D87FE1CQ30818478-98062083-B1D5-422E-A5C3-C6FB9228DD62Q31094266-A690F2C6-E34F-43AD-8DAD-56BE235EDDB2Q33488312-CB32346E-362E-48F8-AD67-85A58099744AQ33567392-8C3ED4FC-396E-48E4-953E-D583DD3D3B5CQ33592297-81BBED7C-C62B-430C-903C-AE28234D89E6Q33642718-22BD54EB-14A1-471B-96D9-5A9B0C447E80Q33643637-EACB127A-8F70-48E1-97F4-7969B564A53BQ33693855-64C94635-8A00-4AC1-88C5-9F9EA4C4CC74Q33718213-17E79AF8-BE98-4ED8-AD85-220C46DBB4F8Q33724582-52B2A7B6-46A9-4AE1-ADF4-E1EF3EA1455BQ33730381-144E8180-0EF2-4D40-90AE-8483281A7529Q33752209-3E7FCF5E-E68D-4E5A-8118-08C48C7C63A5Q33755508-336BA106-85F8-4B4E-88FA-FAB4D19647FBQ33759403-B13A3814-5DD5-44EB-ACA2-C0AFF13F84AAQ33761358-12368B93-ED54-4BC5-938C-E5A8968A22ACQ33784058-31B74588-6A3E-45C9-85B0-10DAC6955125Q33811888-28C09DD0-2E98-47A8-8067-9F7B3F60001EQ33852833-B705ABEB-F9B3-460D-901D-904EADCF050DQ33886704-3D1DAF53-7FE1-4206-A3E6-E133577A5AF7Q33921977-8DD46C99-2016-4B67-92A4-FCB84BD0F503Q33922012-1D455E52-885D-4193-9795-6D5FDD3666E5Q33991058-5D8D4398-780E-43E2-A98B-545EE4B82C3BQ34084147-989AE690-E2BE-4B29-98AF-354DA724A27FQ34103377-E01049A5-6AA4-491B-8F07-646E3A8B922DQ34251217-D8FD5B49-3FE2-45B7-99FC-5F0A6BEB0E13Q34373579-E7F41F8C-81B8-4E68-9CF0-CF42D5D896D1Q34432046-6346B04D-0859-4F08-A698-63F4E15A4501
P2860
Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Time to recovery, chronicity, ...... ive follow-up of 431 subjects.
@en
Time to recovery, chronicity, ...... ive follow-up of 431 subjects.
@nl
type
label
Time to recovery, chronicity, ...... ive follow-up of 431 subjects.
@en
Time to recovery, chronicity, ...... ive follow-up of 431 subjects.
@nl
prefLabel
Time to recovery, chronicity, ...... ive follow-up of 431 subjects.
@en
Time to recovery, chronicity, ...... ive follow-up of 431 subjects.
@nl
P2093
P1433
P1476
Time to recovery, chronicity, ...... ive follow-up of 431 subjects.
@en
P2093
J Endicott
M B Keller
P W Lavori
R M Hirschfeld
T I Mueller
P304
P356
10.1001/ARCHPSYC.1992.01820100053010
P407
P577
1992-10-01T00:00:00Z